These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7272149)

  • 1. Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity.
    Baraka A; Wakid N; Mansour R; Haddad W
    Br J Anaesth; 1981 Aug; 53(8):849-51. PubMed ID: 7272149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neostigmine and pyridostigmine on serum cholinesterase activity.
    Mirakhur RK; Lavery TD; Briggs LP; Clarke RS
    Can Anaesth Soc J; 1982 Jan; 29(1):55-8. PubMed ID: 7055744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neostigmine and pyridostigmine on serum cholinesterase activity.
    Mirakhur RK; Clarke RS; Collier PS
    Can Anaesth Soc J; 1982 May; 29(3):287. PubMed ID: 7074413
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum cholinesterase activity following pancuronium and antagonism with neostigmine or pyridostigmine.
    Stoelting RK
    Anesthesiology; 1976 Dec; 45(6):674-8. PubMed ID: 984487
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure.
    Bishop MJ; Hornbein TF
    Anesthesiology; 1983 Apr; 58(4):384-6. PubMed ID: 6340560
    [No Abstract]   [Full Text] [Related]  

  • 7. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neostigmine and pyridostigmine at the neuromuscular junction.
    Gillies JD; Allen J
    Clin Exp Neurol; 1977; 14():271-9. PubMed ID: 616607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.
    Miller RD; Dennissen PA; van der Pol F; Agoston S; Booij LH; Crul JF
    J Pharm Pharmacol; 1978 Nov; 30(11):699-702. PubMed ID: 31433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of cholinesterase inhibitors.
    Aquilonius SM; Hartvig P
    Clin Pharmacokinet; 1986; 11(3):236-49. PubMed ID: 3524957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Aminopyridine potentiates neostigmine and pyridostigmine in man.
    Miller RD; Booij LH; Agoston S; Crul JF
    Anesthesiology; 1979 May; 50(5):416-20. PubMed ID: 453559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligated renal pedicles and duration of action of neostigmine and pyridostigmine.
    Miller RD; Roderick L
    Br J Pharmacol; 1977 Aug; 60(4):555-8. PubMed ID: 907868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block.
    Gyermek L; Cantley EM; Lee C
    Br J Anaesth; 1995 Apr; 74(4):410-4. PubMed ID: 7734260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The simultaneous monitoring of plasma levels of neostigmine and pyridostigmine in man.
    Davison SC; Hyman N; Prentis RA; Dehghan A; Chan K
    Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):77-82. PubMed ID: 7339332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine.
    Long G; Marsh HM
    Anaesth Intensive Care; 1981 May; 9(2):144-6. PubMed ID: 7258611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of neostigmine on pyridostigmine bioavailability in myasthenic patients after oral administration.
    Chan K; Davison SC; Dehghan A; Hyman N
    Methods Find Exp Clin Pharmacol; 1981; 3(5):291-6. PubMed ID: 7329157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile and phosphatidylinositol responses of rat trachea to anticholinesterase drugs.
    Shibata O; Tsuda A; Makita T; Iwanaga S; Hara T; Shibata S; Sumikawa K
    Can J Anaesth; 1998 Dec; 45(12):1190-5. PubMed ID: 10051938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the anticholinesterase and anticurare effects of some cholinesterase inhibitors.
    Barrow ME; Johnson JK
    Br J Anaesth; 1966 Jun; 38(6):420-31. PubMed ID: 5944020
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.